CSL Bulk Human Coagulation Factor VIII 500 IU (50 IU/mL) / von Willebrand factor 1200 IU powder for injection vial

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

Von willebrand factor, Quantity: 1200 IU; Factor VIII, Quantity: 500 IU

Mevcut itibaren:

CSL Behring Australia Pty Ltd

INN (International Adı):

Factor VIII,Von willebrand factor

Farmasötik formu:

Injection, powder for

Kompozisyon:

Excipient Ingredients: sodium citrate dihydrate; trometamol; calcium chloride dihydrate; Albumin; sucrose; sodium chloride

Uygulama yolu:

Intravenous

Terapötik endikasyonlar:

von Willebrand disease (VWD) - Treatment of haemorrhage or prevention and treatment of surgical bleeding in patients with VWD, when desmopressin (DDAVP) treatment alone is ineffective or contraindicated. Haemophilia A (congenital FVIII deficiency) - Prophylaxis and treatment of bleeding in patients with haemophilia A.

Ürün özeti:

Visual Identification: A white or pale yellow, hygroscopic powder or friable solid; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Yetkilendirme durumu:

Licence status A

Yetkilendirme tarihi:

2013-09-02